V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017553 | 220008309 | null | 104.2 | Curative (C) | 2015-06-10 | 2015-06-10 | Cyclophosphamide+Fludara+TBI Allo | N | null | 220031581 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017554 | 220008310 | 1.64 | 60.3 | Curative (C) | 2013-07-10 | 2013-10-25 | RUXOLITINIB | 01 | N | 220031587 | RUXOLITINIB |
| 220017555 | 220008312 | 1.95 | 72.4 | Disease modification (D) | 2016-05-26 | 2016-05-26 | IDARUBICIN + TRETINOIN | N | N | 220031588 | IDARUBICIN + TRETINOIN |
| 220017556 | 220017930 | 1.8 | 16.9 | Adjuvant (A) | 2015-08-26 | 2015-10-07 | ATG + Busulfan + Fludarabine | N | Y | 220031603 | ATG + BUSULFAN + FLUDARABINE |
| 220017557 | 220008318 | null | 81.4 | Not known (9) | 2014-10-03 | 2014-10-04 | AML16 DA 3+8 | null | null | 220031606 | AML16 TRIAL |
| 220017558 | 220008320 | null | 68.5 | Palliative (P) | 2013-06-21 | 2013-06-22 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220031607 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017559 | 220008325 | null | null | Palliative (P) | 2018-08-05 | 2019-05-07 | BOSUTINIB | N | null | 220031609 | BOSUTINIB |
| 220017560 | 220017933 | 1.8 | 66.4 | Palliative (P) | 2018-10-28 | 2018-11-03 | BOSUTINIB | 02 | N | 220031612 | BOSUTINIB |
| 220017561 | 220008326 | 1.6 | 54.6 | Palliative (P) | 2014-11-16 | 2014-11-22 | BOSUTINIB | null | N | 220031621 | BOSUTINIB |
| 220017562 | 220008330 | 1.64 | null | Not known (9) | 2017-06-15 | 2017-11-20 | BOSUTINIB | 02 | N | 220031623 | BOSUTINIB |
| 220017563 | 220008331 | 1.8 | 68.8 | Curative (C) | 2017-12-22 | 2018-02-14 | IDARUBICIN + TRETINOIN | N | N | 220031625 | IDARUBICIN + TRETINOIN |
| 220017564 | 220014526 | 1.5 | 17.05 | Curative (C) | 2016-07-14 | 2016-07-14 | IDARUBICIN + TRETINOIN | 02 | N | 220031628 | IDARUBICIN + TRETINOIN |
| 220017565 | 220008335 | 1.62 | null | Curative (C) | 2017-04-04 | 2017-05-09 | FLAG | Y | N | 220031645 | FLAG |
| 220017567 | 220008337 | 1.66 | 54.8 | Disease modification (D) | 2016-12-12 | 2016-12-12 | ATG + Busulfan + Fludarabine | N | null | 220031653 | ATG + BUSULFAN + FLUDARABINE |
| 220017568 | 220008339 | 1.63 | 71.45 | Curative (C) | 2014-02-21 | 2014-02-21 | BOSUTINIB | N | N | 220031663 | BOSUTINIB |
| 220017569 | 220014530 | 1.68 | 67 | Disease modification (D) | 2014-10-02 | 2014-11-14 | BOSUTINIB | N | N | 220031680 | BOSUTINIB |
| 220017570 | 220019843 | 0 | null | Curative (C) | 2016-10-26 | 2016-12-06 | FLAG | 2 | N | 220031681 | FLAG |
| 220017571 | 220008344 | 1.65 | 78.5 | Curative (C) | 2013-04-04 | 2013-04-04 | ATG + Busulfan + Fludarabine | N | N | 220031687 | ATG + BUSULFAN + FLUDARABINE |
| 220017572 | 220008349 | null | null | null | 2014-11-13 | 2014-11-13 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220031688 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017573 | 220008351 | 1.25 | 66.1 | Curative (C) | 2014-11-03 | 2017-05-24 | ATG + Busulfan + Fludarabine | N | null | 220031700 | ATG + BUSULFAN + FLUDARABINE |
| 220017574 | 220008353 | 0 | 0 | Disease modification (D) | 2017-01-09 | 2017-01-09 | Cyclophosphamide TBI Allograft | 02 | N | 220031700 | CYCLOPHOSPHAMIDE |
| 220017575 | 220008357 | 1.01 | 73.5 | null | 2016-10-28 | 2017-02-12 | BOSUTINIB | Y | N | 220031734 | BOSUTINIB |
| 220017576 | 220008358 | 1.57 | 0 | Curative (C) | 2013-09-29 | 2013-09-30 | Idarubicin+Tretinoin Spanish Crse4 | Y | N | 220031735 | IDARUBICIN + TRETINOIN |
| 220017577 | 220008361 | 1.5 | 60.8 | Curative (C) | 2014-05-13 | 2014-06-25 | RUXOLITINIB | N | Y | 220031736 | RUXOLITINIB |
| 220017578 | 220008362 | 0 | null | Disease modification (D) | 2013-04-13 | 2013-07-04 | CYCLOPHOSPHAMIDE + FLUDARABINE | 01 | N | 220031736 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017581 | 220008367 | 1.67 | 78 | Curative (C) | 2014-03-09 | 2014-03-09 | ATG + Busulfan + Fludarabine | 02 | N | 220031749 | ATG + BUSULFAN + FLUDARABINE |
| 220017582 | 220014541 | 1.72 | null | Curative (C) | 2017-10-04 | 2017-10-10 | Cyclophosphamide+Fludara+TBI Allo | N | null | 220031749 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017583 | 220014542 | null | 82 | Curative (C) | null | 2014-01-21 | Triple / Double Intrathecal Therapy | N | null | 220031774 | TRIPLE INTRATHECAL |
| 220017584 | 220008370 | 1.56 | 54 | Curative (C) | 2014-07-04 | 2014-07-04 | Triple Intrathecal | 02 | N | 220031784 | TRIPLE INTRATHECAL |
| 220017585 | 220008374 | null | 10.6 | Curative (C) | 2012-11-22 | 2013-05-17 | AML16 DA 2+5 | N | null | 220031792 | AML16 TRIAL |
| 220017586 | 220008377 | 1.68 | 63.1 | Curative (C) | 2016-06-20 | 2016-06-21 | AML16 Low Dose Cytarabine | N | null | 220031796 | AML16 TRIAL |
| 220017587 | 220008378 | 1.6 | 60 | Palliative (P) | null | 2018-10-21 | BOSUTINIB | N | N | 220031797 | BOSUTINIB |
| 220017588 | 220008381 | 0 | 8.3 | Disease modification (D) | 2014-02-02 | 2014-02-02 | FLAG | 02 | N | 220031799 | FLAG |
| 220017590 | 220008388 | 1.52 | 63.5 | Disease modification (D) | 2018-09-20 | 2018-09-20 | AML16 DA 3+10 | 02 | N | 220031813 | AML16 TRIAL |
| 220017593 | 220008391 | 1.65 | 14.6 | Adjuvant (A) | 2016-03-24 | 2016-04-20 | BOSUTINIB | N | N | 220031820 | BOSUTINIB |
| 220017594 | 220017949 | 1.81 | 68.8 | Curative (C) | 2014-01-11 | 2014-01-11 | Methotrexate intrathecal | N | Y | 220031821 | METHOTREXATE INTRATHECAL |
| 220017595 | 220008395 | null | 90.4 | Curative (C) | 2010-05-25 | 2013-12-30 | FLAG | N | N | 220031843 | FLAG |
| 220017596 | 220008395 | 1.65 | 67.6 | Curative (C) | 2016-05-28 | 2016-06-03 | FLAG | N | N | 220031843 | FLAG |
| 220017597 | 220008397 | null | 76.2 | Curative (C) | 2017-09-03 | 2017-12-28 | Triple Intrathecal | N | null | 220031869 | TRIPLE INTRATHECAL |
| 220017598 | 220014552 | 1.6 | null | Curative (C) | 2017-03-07 | 2017-08-07 | AML16 DA 3+10 | N | N | 220031880 | AML16 TRIAL |
| 220017599 | 220014553 | 1.79 | 73.6 | Palliative (P) | 2014-07-17 | 2014-07-18 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220031880 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017600 | 220014554 | null | 106.8 | Curative (C) | 2015-09-17 | 2015-09-18 | Triple Intrathecal | N | N | 220031890 | TRIPLE INTRATHECAL |
| 220017601 | 220019856 | 1.56 | 25.8 | null | 2018-03-02 | 2018-07-12 | BOSUTINIB | N | N | 220031895 | BOSUTINIB |
| 220017602 | 220008403 | 1.74 | 41 | Curative (C) | 2015-09-27 | 2015-09-27 | CYCLOPHOSPHAMIDE | N | N | 220031895 | CYCLOPHOSPHAMIDE |
| 220017603 | 220008406 | null | 102 | Disease modification (D) | 2016-09-06 | 2016-09-06 | IDARUBICIN + TRETINOIN | N | N | 220031907 | IDARUBICIN + TRETINOIN |
| 220017604 | 220008407 | 1.73 | 0 | null | 2014-09-24 | 2014-09-30 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | Y | 220031919 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017605 | 220008408 | 1.7 | 83 | Disease modification (D) | 2013-11-18 | 2013-12-04 | Idarubicin+Tretinoin Spanish Crse4 | 02 | N | 220031924 | IDARUBICIN + TRETINOIN |
| 220017606 | 220008413 | null | 87.3 | Disease modification (D) | 2016-02-20 | 2016-04-02 | IDARUBICIN + TRETINOIN | N | null | 220031935 | IDARUBICIN + TRETINOIN |
| 220017609 | 220017958 | 1.78 | 82.2 | Curative (C) | 2016-12-19 | 2017-01-27 | Triple Intrathecal | 02 | N | 220031947 | TRIPLE INTRATHECAL |
| 220017610 | 220008423 | 1.79 | 53.6 | Disease modification (D) | 2014-07-29 | 2014-11-19 | AML Int Guide ADE 10+3+5 (1) | N | N | 220031952 | ADE |